AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 142 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $656,683 | +73.7% | 155,612 | +27.6% | 0.00% | – |
| Q2 2023 | $378,157 | +12.0% | 121,986 | -49.8% | 0.00% | – |
| Q1 2023 | $337,578 | +37.4% | 242,862 | +96.7% | 0.00% | – |
| Q4 2022 | $245,739 | -0.9% | 123,487 | +0.5% | 0.00% | – |
| Q3 2022 | $248,000 | -37.2% | 122,829 | -1.1% | 0.00% | – |
| Q2 2022 | $395,000 | -23.7% | 124,245 | -0.0% | 0.00% | – |
| Q1 2022 | $518,000 | – | 124,253 | +161267.5% | 0.00% | – |
| Q2 2020 | $0 | – | 77 | -22.2% | 0.00% | – |
| Q1 2020 | $0 | – | 99 | 0.0% | 0.00% | – |
| Q4 2019 | $0 | – | 99 | 0.0% | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 99 | -100.0% | 0.00% | -100.0% |
| Q2 2019 | $72,109,000 | -30.2% | 10,056,968 | +37.9% | 0.01% | -33.3% |
| Q1 2019 | $103,373,000 | +4.5% | 7,295,225 | -0.2% | 0.01% | -14.3% |
| Q4 2018 | $98,912,000 | -55.6% | 7,310,555 | -27.2% | 0.01% | -44.0% |
| Q3 2018 | $222,767,000 | +70.9% | 10,039,109 | +26.4% | 0.02% | +66.7% |
| Q2 2018 | $130,351,000 | – | 7,943,403 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
| Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
| TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
| Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
| THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
| GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
| XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
| PA Capital LLC | 33,874 | $132,000 | 0.09% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |